FDA震怒?!诺和诺德瞒报死亡、中风与自杀倾向,司美、利拉鲁肽遭警告

药闻天下
Yesterday

01一份致使市值蒸发数十亿的“重磅”警告信2026年3月,医药资本市场再度被一只“黑天鹅”惊扰。就在几天前,全球“减肥药之王”诺和诺德的股价在单日内应声下跌超 3%,数十亿美元市值瞬间蒸发。引发这场震荡的,不是临床试验的失败,也不是供应链的断裂,而是一纸来自美国FDA科学调查办公室、长达8页的严厉警告信。来源:警告信警告信原文:FDA对诺和诺德的警告信_原文.pdf这封标注日期为2026年3月5日...

Source Link

Disclaimer: Investing carries risk. This is not financial advice. The above content should not be regarded as an offer, recommendation, or solicitation on acquiring or disposing of any financial products, any associated discussions, comments, or posts by author or other users should not be considered as such either. It is solely for general information purpose only, which does not consider your own investment objectives, financial situations or needs. TTM assumes no responsibility or warranty for the accuracy and completeness of the information, investors should do their own research and may seek professional advice before investing.

Most Discussed

  1. 1
     
     
     
     
  2. 2
     
     
     
     
  3. 3
     
     
     
     
  4. 4
     
     
     
     
  5. 5
     
     
     
     
  6. 6
     
     
     
     
  7. 7
     
     
     
     
  8. 8
     
     
     
     
  9. 9
     
     
     
     
  10. 10